Clear-Cut Medical
Miriam joined Clear-Cut at the beginning of 2020, bringing with her more than a decade of clinical and regulatory experience in the medical device field with a proven track record of FDA, PMDA and CE market clearances. Miriam held VP Clinical & Regulatory roles at Israeli companies in the cardiovascular space including CathWorks, a company focused on non-invasive FFR technologies for cardiac PCI decision-making, where she was in charge of clinical activity through successful 510(k) clearance of the device, and InspireMD, a company focused on coronary and carotid stenting, where she managed large scale RCTs. Miriam holds a Ph.D. in Neurosciences from the Weizmann Institute of Science and completed Post Doctorate studies in cardiac development.
This person is not in any offices
Clear-Cut Medical
Clear-Cut Medical is a medical device company based in Rehovot, Israel with a US subsidiary in Minneapolis, Minnesota that is dedicated to improving the quality of care for cancer patients through its novel intra-operative MRI technology. The company has developed the compact, mobile, affordable and easy to use ClearSight™ system for excised tissue assessment. The system utilizes state of the art proprietary MRI technology for real time tissue margin assessment. Clinical trial results of the ClearSight™ system in breast conserving surgery have shown high sensitivity and specificity and it will be commercialized with the objective of significantly reducing the need for repeat surgery in Lumpectomy patients.